Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
1
14%
Ph not_applicable
5
71%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
Enrolling by invitation1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

not_yet_recruiting114%
completed343%
enrolling_by_invitation114%
recruiting114%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7